Elevance Health (ELV) Q4 CY2024 Highlights: Revenue: $45.44 billion vs analyst estimates of $45.34 billion (6.6% year-on-year growth, in line) Adjusted EPS: $3.84 vs analyst expectations of $3.85 ...

Health insurance provider Elevance Health (NYSE:EVH) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 6.6% year on year to $45.44 billion. Its non-GAAP profit of $3.84 per share was ...

The 15-year, $7 million agreement will allow IU Health to attach its name and logo to the Nickel Plate Trail, Fishers AgriPark, Spark!Fishers 5K, Fishers Farmers Market and Fishers Community ...

there are also significant risks from not taking timely action to enable the broad and equitable health benefits that are possible from AI. The Guiding Principles recognize the importance of ...

Bone broth, a nutrient-rich liquid made from simmering animal bones in water, is one of those health trends that just keeps going strong. On social media, many swear by drinking the thick ...

$1,210,000 of ELEVANCE HEALTH ... Authorization Mental Health Parity Facilitating Accountability in Reimbursements Act (FAIR Act) (H.R. 3417) Site-based Invoicing and Transparency Enhancement ...

“This project represents a pivotal step toward enhancing transparency and accountability in health care spending and purchasing, ultimately benefiting employers and their employees and families.” ...

Analysts' ratings for Elevance Health (NYSE:ELV) over the last quarter vary from bullish to bearish, as provided by 6 analysts. Summarizing their recent assessments, the table below illustrates ...

In a report released today, Stephen Baxter from Wells Fargo maintained a Buy rating on Elevance Health (ELV – Research Report), with a price target of $478.00. The company’s shares closed ...

As you can see from the chart above the percentage of shares that are sold short for Elevance Health has grown since its last report. This does not mean that the stock is going to fall in the near ...